Users Online: 208
Home Print this page Email this page Small font size Default font size Increase font size
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2016  |  Volume : 1  |  Issue : 2  |  Page : 94-96

Olanzapine induced neutropenia: Rechallenging with olanzapine combined with lithium

1 Department of Neuroscience, College of Medicine, Al-Imam Mohammed Bin Saud Islamic University, Riyadh, Saudi Arabia
2 Al Amal Mental Health Complex, Riyadh, Saudi Arabia

Correspondence Address:
Asem A Alageel
Department of Neuroscience, College of Medicine, Al-Imam Mohammed Bin Saud Islamic University, P.O. Box 26181, 11486 Riyadh
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijas.ijas_23_16

Rights and Permissions

Olanzapine is an atypical antipsychotic medication and a very effective treatment for schizophrenia. However, it is associated with third highest incidence of neutropenia among all antipsychotics, and this may limit its use. We present a case of a schizophrenic female who was successfully treated with olanzapine and lithium to enhance white blood cells after a history of neutropenia caused by olanzapine treatment. We briefly discuss the use of lithium in patients who were rechallenged with antipsychotic medications. This case study supports the use of lithium for olanzapine-induced neutropenia as a successful and safe strategy.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded318    
    Comments [Add]    

Recommend this journal